Method for molecular diagnosis of tumor angiogenesis and metastasis
US5942385A · kind A · utility
74Cited by
3References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 21, 1996 |
| Grant date | Aug 24, 1999 |
| Priority date | — |
| Expiry date | Mar 21, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/112
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention is directed to methods of assessing the molecular stage of an disease characterized by abnormal angiogenesis. More particularly, the invention is directed to a method of determining the metastatic potential of a tumor by determining the presence of specific molecular markers. The invention is based in part on the discovery that the key marker for determining the eventual metastasis of a tumor is vascular endothelia growth factor. Knowledge of the particular markers present in a tumor condition allows the physician to tailor cancer treatment and manage the disease condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.